Royalty Pharma Ownership | Who Owns Royalty Pharma?
Royalty Pharma Ownership Summary
Royalty Pharma is owned by 80.59% institutional investors, 8.74% insiders, and 10.68% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.84% of RPRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.77% of its assets in Royalty Pharma shares.
RPRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Royalty Pharma | 80.59% | 8.74% | 10.68% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Morgan stanley | 44.13M | 9.84% | $1.16B |
Vanguard group | 37.35M | 8.34% | $952.90M |
Blackrock funding, inc. /de | 25.43M | 6.00% | $916.20M |
Fmr | 26.38M | 5.89% | $672.94M |
Capital investors | 21.88M | 5.17% | $788.36M |
Blackrock | 23.02M | 5.13% | $606.97M |
Baillie gifford | 14.13M | 3.16% | $360.57M |
Swedbank ab | 12.16M | 2.87% | $438.03M |
State street | 9.49M | 2.11% | $250.17M |
Geode capital management | 7.31M | 1.63% | $186.85M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
New south capital management | 2.89M | 5.04% | $104.00M |
Patient capital management | 2.99M | 4.86% | $107.66M |
Cutter capital management, lp | 356.89K | 4.84% | $11.11M |
Regal partners | 1.35M | 4.10% | $48.47M |
Caledonia (private) investments pty | 6.44M | 3.69% | $232.20M |
Torray investment partners | 688.78K | 3.60% | $24.82M |
Menlo advisors | 131.32K | 2.55% | $4.73M |
Ctf capital management, lp | 100.00K | 2.13% | $3.60M |
Inlet private wealth | 234.84K | 2.08% | $8.46M |
Cannon global investment management | 25.00K | 1.84% | $900.75K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital investors | 21.88M | 0.14% | 21.88M |
Norges bank | 4.88M | 0.02% | 4.88M |
Blackrock | 23.02M | 0.01% | 1.81M |
Bnp paribas arbitrage, snc | 1.64M | 0.02% | 1.64M |
Arrowstreet capital, limited partnership | 2.98M | 0.08% | 1.62M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Viking global investors lp | 2.60M | 0.27% | -7.97M |
Unisphere establishment | - | - | -5.00M |
Gmt capital | - | - | -2.38M |
Siguler guff advisers | - | - | -2.37M |
Millennium management | 309.17K | 0.01% | -2.11M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Capital investors | 21.88M | 0.14% | 21.88M | $788.36M |
Norges bank | 4.88M | 0.02% | 4.88M | $124.50M |
Bnp paribas arbitrage, snc | 1.64M | 0.02% | 1.64M | $41.96M |
Capital, inc./ca/ | 661.54K | 0.23% | 661.54K | $23.84M |
Cartesian growth | 387.57K | 0.24% | 387.57K | $9.89M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -2.00 |
Central trust | -3.00 |
Harbor investment advisory | -4.00 |
New millennium group | -11.00 |
Td waterhouse canada | -13.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 456 | -1.30% | 341,289,005 | 7.83% | 80 | 1.51% | 248 | - | 148 | 2.07% |
Mar 31, 2025 | 3 | -99.28% | 2,405,220 | -99.25% | - | 0.01% | 1 | -99.58% | 2 | -98.51% |
Dec 31, 2024 | 382 | -3.78% | 305,326,416 | -0.72% | 68 | 1.45% | 210 | -2.78% | 129 | 6.61% |
Sep 30, 2024 | 394 | 3.14% | 307,455,539 | -2.73% | 68 | 1.40% | 214 | 6.47% | 120 | -4.76% |
Jun 30, 2024 | 377 | -1.57% | 316,067,573 | 2.80% | 70 | 1.49% | 201 | -8.22% | 123 | 6.03% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 12.01M | 2.77% | -167.60K |
Vanguard Total Stock Mkt Idx Inv | 11.25M | 2.60% | -258.49K |
Vanguard Mid Cap Index Institutional | 7.99M | 1.85% | 86.30K |
Capital Group New Perspective Comp | 7.08M | 1.68% | 7.08M |
American Funds New Perspective A | 7.08M | 1.68% | 7.08M |
Morgan Stanley Inst Growth I | 5.94M | 1.38% | 580.21K |
Morgan Stanley Growth | 5.94M | 1.38% | 261.46K |
Morgan Stanley Growth SMA | 5.94M | 1.38% | 261.46K |
MS INVF US Advantage I | 5.41M | 1.25% | - |
MS INVF US Growth I | 4.59M | 1.06% | -45.55K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 11, 2025 | Norden Gregory | - | Sell | $1.21M |
Jan 03, 2024 | RIGGS RORY B | - | Sell | $5.53M |
Jan 02, 2024 | RIGGS RORY B | - | Sell | $6.71M |
Jan 04, 2024 | RIGGS RORY B | - | Sell | $983.50K |
Dec 29, 2023 | Avara Management Ltd | - | Sell | $1.85M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 1 |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
RPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools